These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28439054)

  • 1. [Calcium and bone metabolism across women's life stages. The effects of oral contraceptives/low dose estrogen-progestin on bone metabolism, bone mass and geometry in adolescent and young adult women.].
    Okano H
    Clin Calcium; 2017; 27(5):661-671. PubMed ID: 28439054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of contraceptive use on bone biochemical markers in young women.
    Ott SM; Scholes D; LaCroix AZ; Ichikawa LE; Yoshida CK; Barlow WE
    J Clin Endocrinol Metab; 2001 Jan; 86(1):179-85. PubMed ID: 11231998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of progestins on bone quality and fractures.
    Thijssen JH
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():45-52. PubMed ID: 17943539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives: mechanism of action, dosing, safety, and efficacy.
    Sondheimer SJ
    Cutis; 2008 Jan; 81(1 Suppl):19-22. PubMed ID: 18338654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose oral contraception and bone density].
    Karck U; Breckwoldt M
    Ther Umsch; 2001 Sep; 58(9):547-51. PubMed ID: 11594153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls.
    Lattakova M; Borovsky M; Payer J; Killinger Z
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):207-14. PubMed ID: 19565418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Pikkarainen E; Lehtonen-Veromaa M; Möttönen T; Kautiainen H; Viikari J
    Contraception; 2008 Sep; 78(3):226-31. PubMed ID: 18692613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity.
    Taes Y; Lapauw B; Vandewalle S; Zmierczak H; Goemaere S; Vanderschueren D; Kaufman JM; T'Sjoen G
    Bone; 2009 Aug; 45(2):392-7. PubMed ID: 19376280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oral contraceptive on bone metabolism.
    Trémollieres F
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):47-53. PubMed ID: 23384745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone health in estrogen-free contraception.
    Hadji P; Colli E; Regidor PA
    Osteoporos Int; 2019 Dec; 30(12):2391-2400. PubMed ID: 31446440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium and bone metabolism across women's life stages. Bone metabolism and estrogen/androgen balance in women.].
    Yasui T; Fukuoka M
    Clin Calcium; 2017; 27(5):673-682. PubMed ID: 28439055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hormonal contraceptives on bone turnover markers and bone health.
    Herrmann M; Seibel MJ
    Clin Endocrinol (Oxf); 2010 May; 72(5):571-83. PubMed ID: 19740118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.